Alexion Pharmaceuticals Inc. (ALXN)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 219.50m
  • Volume: 0
  • RiskGrade: 193

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Continuing Operations          
Revenue 6,069.90 4,991.10 4,131.20 3,551.10 3,084.10
Operating Profit/(Loss) 632.30 2,120.40 269.60 627.40 667.40
Profit Before Tax 569.00 2,178.80 242.20 547.80 576.20
Profit After Tax 603.40 2,404.30 77.60 443.30 399.40
           
Earnings per Share - Basic 274.00¢ 1,077.00¢ 35.00¢ 198.00¢ 178.00¢
Earnings per Share - Adjusted 274.00¢ 1,077.00¢ 35.00¢ 198.00¢ 178.00¢
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Assets          
Non-Current Assets          
Property, Plant & Equipment 1,461.90 1,367.30 1,471.50 1,325.40 1,035.60
Intangible Assets 8,102.50 8,381.70 8,678.70 8,991.80 9,340.50
Other Non-Current Assets 2,705.60 2,719.20 396.70 312.20 299.00
  12,270.00 12,468.20 10,546.90 10,629.40 10,675.10
Current Assets          
Inventories 775.70 627.60 472.50 460.40 374.70
Cash at Bank & in Hand 2,964.50 2,685.50 1,365.50 584.40 966.00
Other Current Assets 2,092.80 1,763.30 1,547.00 1,909.10 1,237.50
  5,833.00 5,076.40 3,385.00 2,953.90 2,578.20
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 18,103.00 17,544.60 13,931.90 13,583.30 13,253.30
Current Liabilities          
Borrowings 142.40 126.70 93.80 167.40 190.80
Other Current Liabilities 1,482.30 1,067.60 1,080.20 785.10 632.10
           
Current Liabilities 1,624.70 1,194.30 1,174.00 952.50 822.90
           
Net Current Assets c4,208.30 c3,882.10 c2,211.00 c2,001.40 c1,755.30
           
Borrowings 2,596.70 2,539.10 3,045.90 3,232.50 3,250.60
Other Non-Current Liabilities 2,230.40 2,539.40 546.70 505.20 486.00
Non-Current Liabilities 4,827.10 5,078.50 3,592.60 3,737.70 3,736.60
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 6,451.80 6,272.80 4,766.60 4,690.20 4,559.50
           
Net Assets 11,651.20 11,271.80 9,165.30 8,893.10 8,693.80
           
Shareholders Funds 11,651.20 11,271.80 9,165.30 8,893.10 8,693.80
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 11,651.20 11,271.80 9,165.30 8,893.10 8,693.80
Cash Flow 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Net Cash Flow From Operating Activities 3,002.90 2,084.90 426.00 1,115.60 1,086.30
Net Cash Flow from Investing Activities (2,099.50) 9.70 470.50 (918.30) (287.60)
Net Cash Flow from Financing Activities (592.40) (738.30) (113.60) (578.90) (842.80)
Net Increase/Decrease In Cash 311.00 1,356.30 782.90 (381.60) (44.10)
Ratios - based on IFRS 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Continuing Operations          
PE Ratio - Adjusted 57.0 10.0 278.2 60.4 68.7
PEG - Adjusted n/a 0.0 n/a 5.5 0.4
Earnings per Share Growth - Adjusted -75% 2,977% -82% 11% 162%
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 2,765.33¢ 2,273.85¢ 1,882.10¢ 1,617.81¢ 1,405.06¢
Pre-Tax Profit per Share 259.23¢ 992.62¢ 110.34¢ 249.57¢ 262.51¢
Operating Margin 10.42% 42.48% 6.53% 17.67% 21.64%
Return on Capital Employed 9.05% 39.22% 6.68% 16.59% 20.62%
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 1,368.06¢ 949.84¢ 194.08¢ 508.25¢ 494.90¢
Cash Incr/Decr per Share 141.69¢ 617.90¢ 356.67¢ (173.85¢) (20.09¢)
Net Asset Value per Share (exc. Intangibles) 1,616.72¢ 1,316.67¢ 221.69¢ (44.97¢) (294.62¢)
Net Gearing -1.93% -0.17% 19.36% 31.66% 28.47%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page